What is the published evidence on the accuracy, turnaround time and cost/cost-effectiveness of tests to identify carbapenemase producing Enterobacteriaceae (CPE) in hospital screening samples obtained from patients identified as at risk of CPE colonisation during clinical risk assessment?
Healthcare Improvement Scotland.
Scottish Health Technologies Group.
"This advice has been produced following completion of evidence note 62 by Healthcare Improvement Scotland, in response to an enquiry from Health Protection Scotland."--page 1.
System requirements: Adobe Reader required to view PDF document.
Description from online resource; title from PDF caption title (Healthcare Improvement Scotland, viewed 2 October 2019)
Communicable diseases
Enterobacteriaceae
Diagnosis, Laboratory